GoHealth Inc. (NASDAQ: GOCO) has announced a challenging financial performance for the third quarter of 2025, with net revenues plummeting to $34.2 million from $118.3 million...
The concept of a K-shaped economy is gaining prominence as financial markets respond in distinct ways to economic recovery. Carol Schleif, chief market strategist at BMO...
Investors reacted sharply to the debut of Navan (NASDAQ: NAVN), with shares plunging by 20% on their opening day of trading. This decline occurred despite the...
Palantir Technologies (NASDAQ: PLTR) has emerged as a major player in the stock market, experiencing a remarkable increase in share price. As of now, the company’s...
UPDATE: Edesa Biotech, Inc. (Nasdaq: EDSA) has just announced groundbreaking results from its Phase 3 study of paridiprubart (EB05) for treating Acute Respiratory Distress Syndrome (ARDS)....
Incyte Corporation (NASDAQ: INCY) is set to report its Q3 2025 earnings on October 28, 2025, before the market opens. Analysts anticipate a strong performance, with...
Sagimet Biosciences has reported promising results from a late-stage clinical trial of its acne treatment, denifanstat. The trial, conducted by its partner, Ascletis Bioscience, in China,...
Tango Therapeutics, a biotechnology company listed on NASDAQ under the ticker symbol TNGX, has successfully priced an underwritten public offering that aims to raise $225 million....
Adaptimmune Therapeutics has announced its decision to initiate the delisting of its American Depositary Shares (ADS) from The Nasdaq Capital Market. Each ADS represents six ordinary...
DeFi Development Corp. (NASDAQ: DFDV) has recently upgraded its investment rating to “Buy,” as it trades near net asset value (NAV). The company is focusing on...
